Trial Profile
Bortezomib With Dexamethasone as the First-line Treatment for Immunoglobulin Light Chain(AL) Amyloidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 06 Jul 2015 New trial record